Author Question: Refer to Exhibit 10-3. Is the causal relationship demonstrated in the study generalizable to other ... (Read 78 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
Refer to Exhibit 10-3. Is the causal relationship demonstrated in the study generalizable to other persons and settings?
 
  a. Internal
  c. Construct
  b. External
  d. Statistical Conclusion

Question 2

Refer to Exhibit 10-3. Were the tests used for analysis appropriate and sufficiently powerful to correctly estimate the size and significance of the effect?
 
  a. Internal
  c. Construct
  b. External
  d. Statistical Conclusion



juliaf

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Tobacco depletes the body of vitamins A, C, and E, which can result in any of the following: dry hair, dry skin, dry eyes, poor growth, night blindness, abscesses, insomnia, fatigue, reproductive system problems, sinusitis, pneumonia, frequent respiratory problems, skin disorders, weight loss, rickets, osteomalacia, nervousness, muscle spasms, leg cramps, extremity numbness, bone malformations, decayed teeth, difficulty in walking, irritability, restlessness, profuse sweating, increased uric acid (gout), joint damage, damaged red blood cells, destruction of nerves, infertility, miscarriage, and many types of cancer.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library